Genetic Technologies drives leadership in precision medicine with Multi-Risk Test
Go back to Genetic Technologies drives leadership in precision medicine with Multi-Risk Test| Genetic Technologies Ltd. (NASDAQ: GENE) | Delayed: 0.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $4.27 | |||
| Open | $0.77 | 52 Week Low | $1.20 | |||
| Day High | $0.77 | P/E | N/A | |||
| Day Low | $0.77 | EPS | $0.00 | |||
| Volume | 215,370 | |||||
| (AMEX: GTG) | Delayed: 1.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $1.00 | |||
| Open | $1.00 | 52 Week Low | $1.00 | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $0.00 | |||
| Volume | 0 | |||||
